This person is not registered. Is this you?


Profile Details
Jing X. Kang
Affiliations:

Harvard University

 
, USA
Phone: (617) 726-8509
Fax: (617) 726-6144
LinkedIN:
My Blogs:
My Twitter Hashtags:
@reubenkang
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Biochemistry, Biology, Biotechnology, Cancer Biology, Drug Design, Genomics, Immunology, Metabolic Syndrome, Microbiology, Molecular Biology, Mutagenesis, Nutrition, Oncology, Proteomics, Thyroid
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 4747 / 2941 (What's this?)
Accomplish Score: 38
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 1277
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 2 (26 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 2 (12 / 0)
  • Purpose: This meta-analysis was aimed to evaluate the role of postoperative concurrent chemoradiotherapy (post-CCRT) for esophageal cancer patients after surgery. ()
  • Triple-negative breast cancer (TNBC) has a higher risk of death within 5 years of being diagnosed than the other forms of breast cancer. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.